Alphatec Holdings Inc ATEC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ATEC is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $12.24
- Day Range
- $12.24–12.68
- 52-Week Range
- $8.66–19.14
- Bid/Ask
- $12.48 / $13.21
- Market Cap
- $1.72 Bil
- Volume/Avg
- 1.3 Mil / 1.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.20
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 839
- Website
- https://www.atecspine.com
Comparables
Valuation
|
Metric
|
ATEC
|
LUNG
|
OBIO
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 22.71 | 2.37 | 2.36 |
Price/Sales | 3.20 | 4.03 | 53.93 |
Price/Cash Flow | — | — | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ATEC
|
LUNG
|
OBIO
|
|---|---|---|---|
Quick Ratio | 1.86 | 5.62 | 7.82 |
Current Ratio | 2.86 | 6.50 | 7.95 |
Interest Coverage | −10.23 | −19.37 | — |
Quick Ratio
ATEC
LUNG
OBIO
Profitability
|
Metric
|
ATEC
|
LUNG
|
OBIO
|
|---|---|---|---|
Return on Assets (Normalized) | −9.89% | −22.61% | −35.16% |
Return on Equity (Normalized) | — | −31.80% | −51.40% |
Return on Invested Capital (Normalized) | −9.94% | −25.75% | −50.12% |
Return on Assets
ATEC
LUNG
OBIO
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Pqkfkcgy | Kmxtmg | $185.4 Bil | |
SYK
| Stryker Corp | Mhpkdfczf | Pbk | $127.7 Bil | |
BSX
| Boston Scientific Corp | Lwkrmcnfl | Zpdxv | $107.6 Bil | |
MDT
| Medtronic PLC | Bllbbqf | Jrwldlg | $105.9 Bil | |
DXCM
| DexCom Inc | Rbhgdhsjj | Mtvs | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Gzjhftlpzt | Txrmf | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Bmvrjmfyd | Tfwl | $24.6 Bil | |
ALGN
| Align Technology Inc | Cvcwsxjpz | Vnwmhx | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Wxcppysh | Hhdrr | $18.7 Bil | |
PODD
| Insulet Corp | Tjpxzkqxgk | Mclxywh | $11.6 Bil |